These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 16475132)

  • 21. [Comparison of valproate level in human plasma, cerebrospinal fluid and brain tissue following administration of various preparations of valproate and valpromide].
    Wieser HG
    Praxis (Bern 1994); 1994 Oct; 83(40):1111-6. PubMed ID: 7939081
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Do results of the recent clinical trials change the place of valproate in treatment of epilepsy?].
    Bosak M
    Przegl Lek; 2008; 65(11):807-9. PubMed ID: 19205366
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Serum valproate levels with oral contraceptive use.
    Herzog AG; Farina EL; Blum AS
    Epilepsia; 2005 Jun; 46(6):970-1. PubMed ID: 15946343
    [No Abstract]   [Full Text] [Related]  

  • 24. Plasma concentration of valproate following substitution of divalproex sodium by valproic acid.
    Dumoulin L; Landry P
    Can J Psychiatry; 2000 Oct; 45(8):761. PubMed ID: 11086560
    [No Abstract]   [Full Text] [Related]  

  • 25. Poor applicability of estimation method for adults to calculate unbound serum concentrations of valproic acid in epileptic neonates and infants.
    Ueshima S; Aiba T; Ishikawa N; Sato T; Kawasaki H; Kurosaki Y; Ohtsuka Y; Sendo T
    J Clin Pharm Ther; 2009 Aug; 34(4):415-22. PubMed ID: 19583674
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Seizure control and side-effect profile after switching adult epileptic patients from standard to extended-release divalproex sodium.
    Pierre-Louis SJ; Brannegan RT; Evans AT
    Clin Neurol Neurosurg; 2009 Jun; 111(5):437-41. PubMed ID: 19181439
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of divalproex sodium on hemoglobin level.
    Taher AT; Musallam KM; Nasreddine W; Perrine SP; El-Hajj TI; Beydoun A
    Blood Cells Mol Dis; 2009; 43(1):49-52. PubMed ID: 19254854
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of epilepsy and valproic acid on oxidant status in children with idiopathic epilepsy.
    Yiş U; Seçkin E; Kurul SH; Kuralay F; Dirik E
    Epilepsy Res; 2009 Apr; 84(2-3):232-7. PubMed ID: 19261443
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Population pharmacokinetics of valproate in Mexican children with epilepsy.
    Correa T; Rodríguez I; Romano S
    Biopharm Drug Dispos; 2008 Dec; 29(9):511-20. PubMed ID: 19067436
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Convulex and its place in epilepsy treatment with original valproates].
    Gromov SA; Kim KV
    Zh Nevrol Psikhiatr Im S S Korsakova; 2002; 102(9):18-21. PubMed ID: 12378876
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The spectrum of valproic acid-associated pancreatitis.
    Werlin SL; Fish DL
    Pediatrics; 2006 Oct; 118(4):1660-3. PubMed ID: 17015559
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Conversion from delayed-release sodium valproate to extended-release sodium valproate: initial results and long-term follow-up.
    McCabe PH; Michel NC; McNew CD; Lehman EB
    Epilepsy Behav; 2006 May; 8(3):601-5. PubMed ID: 16678766
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Valproate treatment of acute alcohol hallucinosis: a double-blind, placebo-controlled study.
    Aliyev ZN; Aliyev NA
    Alcohol Alcohol; 2008; 43(4):456-9. PubMed ID: 18495806
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effectiveness and tolerability of rufinamide in children and adults with refractory epilepsy: first European experience.
    Kluger G; Kurlemann G; Haberlandt E; Ernst JP; Runge U; Schneider F; Makowski C; Boor R; Bast T
    Epilepsy Behav; 2009 Mar; 14(3):491-5. PubMed ID: 19162229
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Bioequivalence in development of antiepileptic drugs.
    Sommerville KW
    Epilepsy Res; 2006 Jan; 68(1):82-5. PubMed ID: 16377144
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [The pharmacological and hormonal effects of carbamazepine and valproic acid in the treatment of reproductive age women with epilepsy].
    Vlasov PN; Karlov VA; Kushlinskiĭ NE
    Zh Nevrol Psikhiatr Im S S Korsakova; 2001; 101(11):26-30. PubMed ID: 11765608
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The effects of carbamazepine, valproic acid and phenobarbital on the oxidative and antioxidative balance in epileptic children.
    Aycicek A; Iscan A
    Eur Neurol; 2007; 57(2):65-9. PubMed ID: 17179706
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Efficacy and tolerability of two formulations of ramipril in Korean adults with mild to moderate essential hypertension: an 8-week, multicenter, prospective, randomized, open-label, parallel-group noninferiority trial.
    Kim SH; Chung WY; Zo JH; Kim MA; Chang HJ; Cho YS; Youn TJ; Chae IH; Choi DJ; Gwak JJ; Lee HY; Park JS; Kang HJ; Kim YJ; Kim HS
    Clin Ther; 2009 May; 31(5):988-98. PubMed ID: 19539099
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Efficacy and safety of mixed amphetamine salts extended release (Adderall XR) in the management of attention-deficit/hyperactivity disorder in adolescent patients: a 4-week, randomized, double-blind, placebo-controlled, parallel-group study.
    Spencer TJ; Wilens TE; Biederman J; Weisler RH; Read SC; Pratt R
    Clin Ther; 2006 Feb; 28(2):266-79. PubMed ID: 16678648
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Rufinamide: clinical pharmacokinetics and concentration-response relationships in patients with epilepsy.
    Perucca E; Cloyd J; Critchley D; Fuseau E
    Epilepsia; 2008 Jul; 49(7):1123-41. PubMed ID: 18503564
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.